BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
238 hedge funds and large institutions have $4.15B invested in Blueprint Medicines in 2022 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 70 increasing their positions, 88 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% more funds holding
Funds holding: 235 → 238 (+3)
0.5% less ownership
Funds ownership: 106.01% → 105.51% (-0.5%)
20% less repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 88
Holders
238
Holding in Top 10
7
Calls
$24.4M
Puts
$14.2M
Top Buyers
| 1 | +$87.3M | |
| 2 | +$36.8M | |
| 3 | +$36.2M | |
| 4 |
BlackRock
New York
|
+$31.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$25.2M |
Top Sellers
| 1 | -$105M | |
| 2 | -$61.2M | |
| 3 | -$44.4M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$38.3M |
| 5 |
CCM
Cadian Capital Management
New York
|
-$37M |